Leona Cloutier
Family · North Conway, NHNPI 1881915775
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,766 of the $3,476 with a category attached, or 79.6%. It is spread thinly across 30 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,013 and has fallen 93.4% since, to $67 in 2025. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $30.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$543
- Astellas Pharma US Inc$500
- E.r. Squibb & Sons, L.L.C.$329
- Bristol Myers Squibb$241
- Seagen Inc.$204
- Daiichi Sankyo Inc.$176
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,76680%
- Education$71120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 18 | $543 |
| Astellas Pharma US Inc | 14 | $500 |
| E.r. Squibb & Sons, L.L.C. | 8 | $329 |
| Bristol Myers Squibb | 4 | $241 |
| Seagen Inc. | 7 | $204 |
| Daiichi Sankyo Inc. | 5 | $176 |
| GSK | 6 | $163 |
| Pfizer | 4 | $148 |
| Amgen | 7 | $140 |
| AstraZeneca | 6 | $140 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $131 |
| Lilly USA, LLC | 1 | $95 |
| AVEO Pharmaceuticals, Inc. | 1 | $89 |
| Beigene USA, Inc. | 4 | $75 |
| Epizyme, Inc. | 3 | $68 |
| Merck | 2 | $48 |
| Sanofi | 3 | $48 |
| Gilead | 2 | $47 |
| Boehringer Ingelheim | 2 | $43 |
| Deciphera Pharmaceuticals Inc. | 2 | $32 |
| Exelixis Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $24 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| AbbVie | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,476 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TabrectaCapmatinib Hydrochloride | 12 | $223,138 |
| Abiraterone Acetate | 15 | $62,004 |
| NuplazidPimavanserin Tartrate | 19 | $46,751 |
| EliquisApixaban | 130 | $42,283 |
| XareltoRivaroxaban | 14 | $10,818 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $9,164 |
| Levetiracetam | 24 | $2,755 |
| OxycontinOxycodone Hcl | 11 | $2,407 |
| Omeprazole | 137 | $1,945 |
| Imatinib Mesylate | 12 | $1,734 |
| Atorvastatin Calcium | 85 | $1,451 |
| Levothyroxine Sodium | 96 | $1,429 |
| Mirtazapine | 27 | $1,291 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 12 | $1,057 |
| Losartan Potassium | 45 | $1,051 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $42,283130 claims |
| Johnson & JohnsonXarelto | $543 | $10,81814 claims |
| GSKTrelegy Ellipta | $163 | $9,16415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 713 family providers in New Hampshire.
Other family in North Conway
- Justine FiermanNorth Conway$2K
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Summer BellDerry$16K
- Laura HudsonDover$14K
- Debra KrisonNorth Hampton$13K
- Michelle WhiteBedford$9K
- Brant OliverConcord$9K
- Cassandra CavanaughDover$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.